Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Connolly

Showing results (51-60 of 118) with videos related to

Pageof 12
Sort By:
Journal of Neuromuscular Diseases|May 31, 2022
Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular DystrophyPaula R Clemens, Vamshi K Rao, Anne M Connolly, et al.
Journal of Child Neurology|September 5, 2006
Longitudinal assessment of neuropsychologic and language function in children with benign rolandic epilepsyEllen Northcott, Anne M Connolly, Jenny McIntyre, et al.
International Journal of Molecular Sciences|October 16, 2024
Taldefgrobep Alfa and the Phase 3 RESILIENT Trial in Spinal Muscular AtrophyLaurent Servais, Lindsey Lee Lair, Anne M Connolly, et al.
Journal of Neuromuscular Diseases|April 3, 2023
Efficacy and Safety of Viltolarsen in Boys With Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension StudyPaula R Clemens, Vamshi K Rao, Anne M Connolly, et al.
JAMA Neurology|May 21, 2019
Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening: Essential StepsMei Baker, Robert Griggs, Barry Byrne, et al.
American Journal of Respiratory and Critical Care Medicine|June 22, 2017
Pulmonary Endpoints in Duchenne Muscular Dystrophy. A Workshop SummaryJonathan Finder, Oscar Henry Mayer, Daniel Sheehan, et al.
Biological Psychiatry|September 27, 2005
Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsyAnne M Connolly, Michael Chez, Elizabeth M Streif, et al.
Muscle & Nerve|June 24, 2011
CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophyChristopher F Spurney, Carolina Tesi Rocha, Erik Henricson, et al.
Muscle & Nerve|February 24, 2015
Electrical impedance myography in Duchenne muscular dystrophy and healthy controls: A multicenter study of reliability and validityCraig M Zaidman, Lucy L Wang, Anne M Connolly, et al.
Muscle & Nerve|May 13, 2016
Clinical Follow-Up for Duchenne Muscular Dystrophy Newborn Screening: A ProposalJennifer M Kwon, Hoda Z Abdel-Hamid, Samiah A Al-Zaidy, et al.
Pageof 12

Showing results (51-60 of 118) with videos related to

Sort By:
Pageof 12
Journal of Neuromuscular Diseases|May 31, 2022
Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular DystrophyPaula R Clemens, Vamshi K Rao, Anne M Connolly, et al.
Journal of Child Neurology|September 5, 2006
Longitudinal assessment of neuropsychologic and language function in children with benign rolandic epilepsyEllen Northcott, Anne M Connolly, Jenny McIntyre, et al.
International Journal of Molecular Sciences|October 16, 2024
Taldefgrobep Alfa and the Phase 3 RESILIENT Trial in Spinal Muscular AtrophyLaurent Servais, Lindsey Lee Lair, Anne M Connolly, et al.
Journal of Neuromuscular Diseases|April 3, 2023
Efficacy and Safety of Viltolarsen in Boys With Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension StudyPaula R Clemens, Vamshi K Rao, Anne M Connolly, et al.
JAMA Neurology|May 21, 2019
Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening: Essential StepsMei Baker, Robert Griggs, Barry Byrne, et al.
American Journal of Respiratory and Critical Care Medicine|June 22, 2017
Pulmonary Endpoints in Duchenne Muscular Dystrophy. A Workshop SummaryJonathan Finder, Oscar Henry Mayer, Daniel Sheehan, et al.
Biological Psychiatry|September 27, 2005
Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsyAnne M Connolly, Michael Chez, Elizabeth M Streif, et al.
Muscle & Nerve|June 24, 2011
CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophyChristopher F Spurney, Carolina Tesi Rocha, Erik Henricson, et al.
Muscle & Nerve|February 24, 2015
Electrical impedance myography in Duchenne muscular dystrophy and healthy controls: A multicenter study of reliability and validityCraig M Zaidman, Lucy L Wang, Anne M Connolly, et al.
Muscle & Nerve|May 13, 2016
Clinical Follow-Up for Duchenne Muscular Dystrophy Newborn Screening: A ProposalJennifer M Kwon, Hoda Z Abdel-Hamid, Samiah A Al-Zaidy, et al.
Pageof 12